The Research & Technology Working Group seeks to bridge the missing mile between basic research and the commercialization of products. Having an equal partnership between academics and healthcare organisations represented by the members of the Virtual Physiological Human Institute (VPHi) and industries engaged in the predictive medicine provides a unique opportunity to explore areas of mutual cooperation and benefit.



The key goals of this group are:

      • Creating links between the VPHi Membership and Avicenna Industry Members
      • Promotion of in silico medicine in Horizon Europe Program
      • Working towards the creation of a certified tissue library for biological materials
      • Work on credibility building for AI technologies and policy asks
      • Medical community outreach


      Priorities in 2022 - 2023 and beyond:

        For current year:

        • Apply for funding for certified tissue library & continue community consensus process;
        • Follow-up activities for AI white paper;
        • Credibility matrix for AI;
        • Develop information packages for clinicians;
        • Develop calls for Horizon Europe WP23-24;
        • Engagement with EMA towards a White Paper on Verification and Validation.

        In 2023:

        • Certified tissue library expansion / funding applications;
        • Promote consortium formation within AA for Horizon Europe;
        • Ecosystem and infrastructure for ISM;
        • Dedicated networks with clinicians;

        In 2024 and beyond:

        • Develop calls for Horizon Europe WP25-27.


        Working group leader:

        Prof. Liesbet Geris, PhD

        Executive Director, VPH Institute

        Professor, University of Liège & KU Leuven (Belgium)



          Avicenna Alliance news

          EU-funded project successfully develops AI software that grows and treats cancerous tumors 

          The Horizon Europe 2020 project EVO-NANO (Evolvable platform for programmable nanoparticle-based cancer...

          find out more ›

          In silico used to validate Omicron variant detection method! 

          The Joint Research Centre (JRC) has developed a new method to detect the Omicron variant of COVID-19, which differs in its nucleic acid...

          find out more ›

          The priorities of the upcoming French Presidency of the Council of the European Union - what’s new for Avicenna? 

          The French Presidency of the Council of the European Union is due to start on 1...

          find out more ›

          In Silico in Innovation – again!

          The European Innovation Council (EIC) has released its second wave of “start-up champions” to receive funding for innovations through the EIC Accelerator. The EIC...

          find out more ›

          Avicenna Alliance meets with MEPs to discuss in silico medicine

          On 7 October, Dr. Liesbet Geris (Research Professor in Biomechanics and Computational Tissue Engineering at the Universities of Liège &...

          find out more ›

          The Joint Research Centre advocates for a “paradigm change” to in silico research methods!

          For the second week in a row, the Joint Research Centre (JRC) – part of the European Commission’s EU Science...

          find out more ›

          The European Commission Joint Research Centre publishes a public knowledge base of non-animal models used in immuno-oncology

          The Joint Research Centre (JRC), which is part of the European...

          find out more ›

          The State of the (European) Union

          On 15 September, Commission President Ursula von der Leyen delivered her second State of the Union speech at the European Parliament in Strasbourg. She took stock of...

          find out more ›

          The BECA Beat 

          The European Parliament’s Special Committee on Beating Cancer (BECA) met for the first time in September of 2020. BECA was established to create actionable recommendations for Member...

          find out more ›

          Avicenna Alliance prepares for the next EU policy session 

          As September begins, politicians have returned to their EU posts and are preparing for what will be a busy few months for health policy. The...

          find out more ›

          Joint Research Centre of the Commission launches report on national strategies for Artificial Intelligence!

          The Joint Research Centre of the European Commission (JRC) recently published a new report...

          find out more ›

          Conference of the Slovenian Council Presidency addresses digital twin technologies and digitalisation in healthcare!

          On 15 and 16 July, the Slovenian Presidency of the Council of the European Union ...

          find out more ›

          WHO issues first global report on use of AI in healthcare

          Artificial Intelligence (AI) applications in health innovation are rapidly increasing, reflecting the potential of these technologies to...

          find out more ›

          Slovenian Presidency of the Council of the EU launches its six-month programme!

          On 1 July, for the second time since joining the EU in 2004, Slovenia has taken over the Presidency of the Council of...

          find out more ›

          Members of the European Parliament call EU Health Commissioner to place in silico medicine on her policy agenda from 2021 onwards!

          On 22 June, a group of five Members of the European Parliament...

          find out more ›

          Our new position paper on in silico evidence in the regulatory approval of medical devices is out!

          The Avicenna Alliance is proud to announce the recent publication of its new position paper...

          find out more ›

          Happy 5th Anniversary to the Avicenna Alliance!  

          5 years ago, based on the very enlightening Avicenna Roadmap Project Report, the Avicenna Alliance was established at the suggestion of European...

          find out more ›

          EU New Medical Device Regulation now in force! In silico mentioned for the first time

          After a one-year postponement following the COVID-19 pandemic, the European Commission’s Medical Devices...

          find out more ›

          The European Commission adopts Communication on Europe's global approach to cooperation in research and innovation

          On 18 May, the European Commission adopted a Communication on its global approach...

          find out more ›

          Avicenna Alliance provides feedback on the European Commissions’ roadmap for the revision of the EU general pharmaceuticals legislation

          On 27 April, the Avicenna Alliance has submitted its feedback...

          find out more ›

          Show all activites

          Sign up for our monthly newsletter!

          Sign up